University of Crete (UOC)
Η δράση φαρμακευτικών ουσιών στην κινητική συμπεριφορά του σώματος και του κατώτερου σφιγκτήρα του οισοφάγου: Προοπτική Κλινικοεργαστηριακή Μελέτη
Abstract
dc:descriptionIt has been confirmed there are various pharmaceutical agents that affect the motility of the esophagus. Erythromycin is one of the macrolide antibiotics with well known gastrokinetic properties, and there is evidence that the drug increases lower esophageal sphincter (LES) pressure. In addition it has been recently shown that sodium valproate increases anal resting pressure in both normals and patients after ileoanal anastomosis. The AIM of the study was to investigate the effect of erythromycin and sodium valproate on the motility of the esophageal body and LES, by stationary manometry in a series of normal subjects and patients with proven gastroesophageal reflux disease. SUBJECTS AND METHOD: Stationary esophageal manometry was performed in 14 healthy subjects and 15 patients with gastroesophageal reflux disease beforre and after i.v. infusion of 200mg erythromycin lactobionate, in a double blind manner. In addition, stationary esophageal manometry was performed in another 10 healthy subjects and 12 patients with gastroesophageal reflux disease before and immediately after a four-day period of sodium valproate administration (400mg every 6 hours, per os). In the morning of the 5th day, before the manometry was performed, blood samples were taken to determine plasma levels of the drug. RESULTS: Erythromycin significantly increased the LES pressure in both controls (p<0.001) and patients (p<0.001), without affecting though LES relaxation after wet swallows. This increase was significantly greater in patients as compared to controls (p=0.005). Erythromycin also increased significantly the amplitude (p=0.002), duration (p=0.003), strength (p=0.014) and velocity (p=0.008) of peristalsis at 5 cm proximal to LES in controls. Finally, erythromycin significantly accelerated the amplitude of peristalsis at 15, 10 and 5cm proximal to LES (p=0.004, p=0.049 and p=0.00L respectively), the duration of peristalsis at 15, 10 and 5cm proximal to LES (p=0.003, p=0.011 and p=0.005, respectively), the strength of peristalsis at 5cm proximal to LES (p=0.001) and the velocity of propagation at distal esophagus (p=0.047). The administration of valproate sodium, failed to modify the parameters of peristalsis of the esophageal body, but resulted in a significant increase of the resting LES pressure in both normal subjects (p=0.045) and patients (p-0.048). CONCLUSION: Erythromycin affects esophageal motility by increasing the strength of peristalsis and the LES pressure both in healthy subjects and in patients with gastroesophageal reflux disease. This action is attributed at least partly through a pregaglionic cholinergic pathway as well as by occupying the motilin receptors on gastrointestinal smooth muscle. Sodium valproate sodium does not seem to affect esophageal body motility, but the drug increases the LES pressure in both healthy subjects and patients with gastroesophageal reflux disease. This action is probably mediated through GABA receptors or alternatively is attributed to the resulted reduction of the somatostatin and consequently of its inhibitory action.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 1996
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzovaras, George
- Τζοβάρας, Γεώργιος
Subjects
dc:subject × 18- Βάλπροϊκό νάτριο
- Γαστροοισοφαγική παλινδρομική νόσος ( ΓΟΠΝ )
- Ερυθρομυκίνη
- Κινητικότητα οισοφάγου
- Μανομετρία οισοφάγου
- Μοτιλίνη
- Erythromycin
- ESOPHAGOAL MOTILITY
- Gastroesophageal reflux disease (GERD)
- Motilin
- Sodium valproate
- Stationary esophageal manometry
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Επιστήμες Υγείας
- Medical and Health Sciences
- Clinical Medicine
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/6047